Literature DB >> 6698986

Purification and characterization of naturally occurring and in vitro induced multiple forms of MM creatine kinase.

S George, Y Ishikawa, M B Perryman, R Roberts.   

Abstract

MM creatine kinase purified from tissue exists as a single form but upon release into the plasma exhibits three forms which, based on increasing anodal migration on polyacrylamide gel electrophoresis, are referred to as MM1, MM2, and MM3. The three forms were isolated in pure form from plasma in sufficient quantities for biochemical and physiological studies. Chromatofocusing results show that MM1, MM2, and MM3 have distinct isoelectric points of 7.58, 7.43, and 7.30, respectively. Analysis on high pressure liquid chromatography showed MM1 and tissue creatine kinase (MMt) to have identical peptide maps, but MM2 and MM3 were different in at least one amino acid. Tissue MM creatine kinase was converted in vitro to MM2 and MM3 after incubation in plasma. Conversion was unaffected by nonspecific proteases but inhibited by benzoylarginine, epsilon-amino caproic acid, and guanidinoethylmercaptosuccinic acid, specific inhibitors of carboxypeptidase N. Digestion of purified tissue MM creatine kinase with carboxypeptidases N and B produced MM2 and MM3 which were identical with the forms produced in vivo. Hybridization experiments with MM1 plus MM3 produced all three forms, as did tissue MM creatine kinase plus MM2. MM2 was also able to produce all three forms in the experiments. The plasma half-life of tissue MM creatine kinase or MM1 was shown to be about one-half that of MM3. The results suggest that hydrolytic cleavage of a basic amino acid, presumably by carboxypeptidase N, is responsible for conversion of MMt to MM2 and MM3. COOH-terminal amino acid analysis demonstrated the COOH-terminal amino acid of canine and rabbit MM1 to be lysine. Thus, we conclude that cleavage of the COOH-terminal lysine from MMt by serum carboxypeptidase N generates two additional MM creatine kinase isoforms with prolonged plasma clearance rates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Molecular biology of heart disease.

Authors:  Robert Roberts
Journal:  World J Cardiol       Date:  2011-04-26

2.  Immunochemical extraction and automated measurement of plasma creatine kinase MB isoenzyme and creatine kinase MB2 isoform.

Authors:  J H McBride; S B Schotters
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Specific proteolytic modification of creatine kinase isoenzymes. Implication of C-terminal involvement in enzymic activity but not in subunit-subunit recognition.

Authors:  H G Lebherz; T Burke; J E Shackelford; J E Strickler; K J Wilson
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

Review 4.  Creatine kinase in the dog: a review.

Authors:  M Aktas; D Auguste; H P Lefebvre; P L Toutain; J P Braun
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

5.  Purification and characterization of cytoplasmic creatine kinase isozymes of Xenopus laevis.

Authors:  J Robert; H R Kobel
Journal:  Biochem Genet       Date:  1988-10       Impact factor: 1.890

6.  Identification by isoelectric focusing of creatine kinase-MM isoforms in the plasma and striated muscle of pigs.

Authors:  F Doizé; L Deroth
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

7.  Several dehydrogenases and kinases compete for endocytosis from plasma by rat tissues.

Authors:  M K Bijsterbosch; A M Duursma; M J Smit; O J Bos; J M Bouma; M Gruber
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

8.  Ficolin-2 inhibitors are present in sera after prolonged storage at -80 °C.

Authors:  Kimball Aaron Geno; Richard E Kennedy; Patricia Sawyer; Cynthia J Brown; Moon H Nahm
Journal:  PeerJ       Date:  2016-11-17       Impact factor: 2.984

9.  Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase.

Authors:  Ragnar P Kristjansson; Asmundur Oddsson; Hannes Helgason; Gardar Sveinbjornsson; Gudny A Arnadottir; Brynjar O Jensson; Aslaug Jonasdottir; Adalbjorg Jonasdottir; G Bragi Walters; Gerald Sulem; Arna Oskarsdottir; Stefania Benonisdottir; Olafur B Davidsson; Gisli Masson; Olafur Th Magnusson; Hilma Holm; Olof Sigurdardottir; Ingileif Jonsdottir; Gudmundur I Eyjolfsson; Isleifur Olafsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Patrick Sulem; Kari Stefansson
Journal:  Nat Commun       Date:  2016-02-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.